LPC
RGNX icon

Lion Point Capital’s Regenxbio RGNX Stock Holding History

Lion Point Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Hold
26,600
– – 1.52% 24
2026
Q1 		$223K Hold
26,600
– – 1.33% 29
2025
Q4 		$383K Sell
26,600
-31,150
-54% -$388K 1.98% 20
2025
Q3 		$557K Hold
57,750
– – 3.17% 16
2025
Q2 		$474K Hold
57,750
– – 3.22% 15
2025
Q1 		$413K Hold
57,750
– – 2.63% 16
2024
Q4 		$446K Hold
57,750
– – 2.34% 17
2024
Q3 		$606K Buy
57,750
+21,500
+59% +$262K 1.35% 16
2024
Q2 		$424K Buy
36,250
+3,750
+12% +$58.4K 0.77% 20
2024
Q1 		$685K Buy
+32,500
New +$578K 0.38% 21

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Lion Point Capital's RGNX Position: Q2 2026 in Review

Lion Point Capital held its Regenxbio (RGNX) position steady in Q2 2026 at 26,600 shares worth $319K. The position accounts for 1.52% of the portfolio, ranked #24.

Lion Point Capital first reported a position in RGNX in Q1 2024 and has held it in 10 quarters since. The position peaked at $685K in Q1 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Lion Point Capital held 26,600 shares of Regenxbio worth $319K as of Q2 2026.
  • Lion Point Capital left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up 1.52% of Lion Point Capital's portfolio in Q2 2026, its #24 holding.
  • Lion Point Capital first reported a position in Regenxbio in Q1 2024 and has held it in 10 quarters since.
  • Lion Point Capital's Regenxbio position peaked at $685K in Q1 2024.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Lion Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.